arrow
返回
J

Jewish Gen Hosp

学者数43
论文数27
被引数17
关联论文 (13)
发表时间
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction The NRG-BR005 Nonrandomized Clinical Trial乳腺癌瘤床活检用于预测病理完全缓解:NRG-BR005非随机临床试验
err2025-05-07
err1
PREAI
errBasik, Mark; Cecchini, Reena S.; de los Santos, Jennifer F.; Umphrey, Heidi R.; Julian, Thomas B.; Mamounas, Eleftherios P.; White, Julia R.; Lucas, Peter C.; Balanoff, Christa R.; Tan, Antoinette R.; Weber, Joseph J.; Edmonson, David A.; Brown-Glaberman, Ursa A.; Diego, Emilia J.; Teshome, Mediget; Matsen, Cindy B.; Seaward, Samantha A.; Wapnir, Irene L.; Wagner, Jamie L.; Tjoe, Judy A.; Thompson, Alastair M.; Wolmark, Norman
err分享
err收藏
Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis循环肿瘤DNA在早期三阴性乳腺癌中的作用:一项系统评价和Meta分析
err2025-03-12
err0
errOAAI
errZhang, Diana; Jahanfar, Shayesteh; Rabinowitz, Judy B.; Dower, Joshua; Song, Fei; Wu, Cherng-Horng; Hu, Xiao; Tracy, Phillip; Basik, Mark; Medford, Arielle; Lin, Po-Han; Huang, Chiun-Sheng; Bidard, Francois-Clement; Renault, Shufang; Pai, Lori; Buss, Mary; Parsons, Heather A.; Schlam, Ilana
err分享
err收藏
Allergic rhinitis过敏性鼻炎
err2024-12-27
err1
errOAAI
errRosenfield, L; Keith, PK; Quirt, J; Small, P; Ellis, AK
err分享
err收藏
Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell LymphomaMosunetuzumab单药治疗在重度预治疗复发或难治性套细胞淋巴瘤患者中显示出令人鼓舞的疗效和可管理的安全性。
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBudde, Elizabeth; Matasar, Matthew; Sehn, Laurie H.; Assouline, Sarit E.; Kuruvilla, John; Flinn, Ian W.; Yoon, Sung-Soo; Bosch, Francesc; Greenwald, Daniel; Gutierrez, Norma C.; Tzachanis, Dimitrios; Marlton, Paula; Mcguirt, Delaney; Yin, Shen; Wei, Michael C.; Kwan, Antonia; Tracy, Samuel; Penuel, Elicia; Bartlett, Nancy L.
err分享
err收藏
SUVR (SUVmax Lymphoma/SUVmax Liver) Vs Deauville Score for Predicting Relapse in Hodgkin LymphomaSUVR(淋巴瘤SUVmax/肝脏SUVmax)与Deauville评分在霍奇金淋巴瘤复发预测中的比较
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRizzolo, Angelo; Ben-Ezra, Noah; Liu, Richard; Salaciak, Matthew; Maliha, Peter; Probst, Stephan; Johnson, Nathalie A.
err分享
err收藏
Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥ 2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II StudyMosunetuzumab 在接受 ≥ 2 种既往治疗(包括有 POD24 病史者)的复发性和/或难治性滤泡性淋巴瘤患者中持续显示出具有临床意义的结果:一项关键性 II 期研究的 4 年随访结果
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errShadman, Mazyar; Bartlett, Nancy L.; Matasar, Matthew; Schuster, Stephen J.; Assouline, Sarit E.; Sehn, Laurie H.; Kuruvilla, John; Giri, Pratyush; Cheah, Chan Y.; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Wei, Michael C.; Yin, Shen; Ma, Connie Y.; Tracy, Samuel; Kwan, Antonia; Penuel, Elicia; Budde, L. Elizabeth
err分享
err收藏